Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|December 16, 2006
Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examinationD J Fowler, I Lindsay, M J Seckl, et al.
Journal of Cellular Physiology|April 1, 1995
Substance P-related antagonists inhibit vasopressin and bombesin but not 5'-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cellsM J Seckl, R H Newman, P S Freemont, et al.
Fetal and Pediatric Pathology|September 24, 2005
Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinomaN J Sebire, I Lindsay, R A Fisher, et al.
Placenta|December 4, 2012
Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutationsN J Sebire, P M Savage, M J Seckl, et al.
Medical Hypotheses|February 8, 2005
Persistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriageN J Sebire, M Foskett, R A Fisher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 8, 2015
Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database reviewA Braga, I Maestá, D Short, et al.
British Journal of Cancer|January 13, 2006
Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?T Powles, P Savage, D Short, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 22, 2005
Overdiagnosis of complete and partial hydatidiform mole in tubal ectopic pregnanciesN J Sebire, I Lindsay, R A Fisher, et al.
British Journal of Cancer|February 18, 2010
The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1)S McGrath, D Short, R Harvey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumorsE S Newlands, P J Mulholland, L Holden, et al.
Pageof 8